The Spanish ministry of science, innovation and universities has awarded IDIBELL a grant (EQC2018-005246-P) worth approximately 93000€ to purchase a Seahorse 96, a high-throughput equipment for cellular metabolism and mitochondrial function analysis. This grant belongs to the 2018 call for the acquisition of scientific-technical equipment within the National R&D&I Plan 2017-2020.
New scientific-technical equipment for IDIBELL Read More »
The risk of developing breast cancer is largely determined by the ability of the cells to repair damage to their DNA and, at the same time, by the regulation of the “stem cells” that may eventually become tumors. However, it is unknown how these two fundamental processes co-regulate. In a recent study, IDIBELL –
New therapeutic strategies for breast cancer Read More »
The Bellvitge Biomedical Research Institute (IDIBELL) states that Dr Manel Esteller, ICREA researcher, professor at the University of Barcelona, and until now, coordinator of the Epigenetics and Cancer Biology Program (PEBC) at IDIBELL, has been appointed director of the Josep Carreras Leukaemia Research Institute, a position that implies the termination of his employment relationship with
Statement on Dr Manel Esteller leaving IDIBELL Read More »
Dr. Álvaro Aytés (IDIBELL – ICO / ProCure) project receives an Idea Development Award from the American Department of Defense (DoD) within its Prostate Cancer Research Program.
400,000 dollars to fight prostate cancer Read More »
Thanks to a bioinformatics analysis of 9,428 tumor samples, vulnerabilities potentially leading to new, more precise treatments are also identified
Bioinformatics deciphers the metabolic characteristics of 25 types of cancer Read More »
Sant Joan de Déu Hospital hosts the event, through which parents will get to know the GRIN2B research team in Barcelona led by Dr. Xavier Altafaj, IDIBELL researcher
Manel Esteller, director of the epigenetics and cancer biology program at IDIBELL, ICREA researcher and professor at the University of Barcelona, has received the Award of the ECO Foundation for Excellence and Quality in Oncology, awarded last Saturday 22nd at the Spanish Royal Academy of Medicine, in Madrid. The foundation has distinguished Dr. Esteller
Dr. Manel Esteller, awarded by the ECO Foundation for Excellence and Quality of Oncology Read More »
These dystrophies are disorders with great clinical and genetic heterogeneity for which there is no cure today; 15,000 people in Spain suffer from them
The 10th BESTPRAC Working Group meeting was held from September 24-25 at the Faculty of Electrical Engineering, University of Belgrade, Serbia and gathered over 100 people from different European countries. IDIBELL attended the meeting as part of the action plan to boost its internationalization. COST BESTPRAC is one of the most relevant networks of research
IDIBELL participates in the COST BESTPRAC meeting held in Belgrade, Serbia Read More »
On the occasion of World Cancer Research Day (WCRD), which takes place every year on September 24th, the Spanish Association Against Cancer (AECC) awarded its 2018 AECC Cancer Research grants. The awards ceremony was chaired by Her Majesty the Queen, as Honorary President of the AECC and the AECC Scientific Foundation. This year, AECC has
IDIBELL researchers receive AECC grants on World Cancer Research Day Read More »
